Acuracet® Tablets
Acuracet® (oxycodone HCl/niacin/APAP) Tablets
Acuracet® is an immediate release opioid analgesic tablet with a proposed indication for relief of moderate-to-severe pain and is designed to deter common methods of misuse and abuse. Acuracet® contains two active analgesics: the opioid oxycodone HCl and acetaminophen (APAP). Acuracet® Tablets are being developed in three tablets strengths of 5/30/325mg, 7.5/30/325mg, and 10/30/325mg.
Status
We opened an Investigation New Drug Application (IND) with the US Food and Drug Administration for Acuracet® in June 2008. Subsequently, we transferred the active IND to King Pharmaceuticals Research and Development, Inc. (King), our development and commercialization partner.
Development Program
We demonstrated bioequivalence of Acuracet® Tablets to the reference listed drug, Percocet®. Ongoing development, manufacture and commercialization of Acuracet® Tablets is the responsibility of King.
Percocet® is a registered trademark of Endo Laboratories, Inc.

